4.7 Article

Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

K. John Pasi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy

Christopher E. Nelson et al.

NATURE MEDICINE (2019)

Article Multidisciplinary Sciences

High levels of AAV vector integration into CRISPR-induced DNA breaks

Killian S. Hanlon et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10

Morgan L. Maeder et al.

NATURE MEDICINE (2019)

Article Hematology

Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research

Kelsey E. Jarrett et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)

Letter Cardiac & Cardiovascular Systems

Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3

Alexandra C. Chadwick et al.

CIRCULATION (2018)

Review Cardiac & Cardiovascular Systems

The Evolving Future of PCSK9 Inhibitors

Robert S. Rosenson et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Biotechnology & Applied Microbiology

Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol

Lili Wang et al.

NATURE BIOTECHNOLOGY (2018)

Article Biotechnology & Applied Microbiology

All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo

Raed Ibraheim et al.

GENOME BIOLOGY (2018)

Article Biotechnology & Applied Microbiology

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing

Hao Yin et al.

NATURE BIOTECHNOLOGY (2017)

Article Medicine, General & Internal

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Marc S. Sabatine et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

Kevin Fitzgerald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A

Savita Rangarajan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Hematology

In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing

Alexandra C. Chadwick et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)

Review Peripheral Vascular Disease

Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing

Alexandra C. Chadwick et al.

CURRENT ATHEROSCLEROSIS REPORTS (2017)

Article Hematology

CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report

Xiao Wang et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)

Article Hematology

Gene therapy for hemophilia: past, present and future

Lindsey A. George et al.

SEMINARS IN HEMATOLOGY (2016)

Article Biotechnology & Applied Microbiology

Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids

Lili Wang et al.

MOLECULAR THERAPY (2015)

Article Multidisciplinary Sciences

In vivo genome editing using Staphylococcus aureus Cas9

F. Ann Ran et al.

NATURE (2015)

Article Biotechnology & Applied Microbiology

GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

Shengdar Q. Tsai et al.

NATURE BIOTECHNOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Evolocumab (AMG 145) for primary hypercholesterolemia

Gisle Langslet et al.

EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)

Article Cardiac & Cardiovascular Systems

An evaluation of alirocumab for the treatment of hypercholesterolemia

Michel Farnier

EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)

Article Cardiac & Cardiovascular Systems

Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing

Qiurong Ding et al.

CIRCULATION RESEARCH (2014)

Article Multidisciplinary Sciences

Selection and evaluation of clinically relevant AAV variants in a xenograft liver model

Leszek Lisowski et al.

NATURE (2014)

Article Medicine, General & Internal

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

A. C. Nathwani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Hematology

Robust ZFN-mediated genome editing in adult hemophilic mice

Xavier M. Anguela et al.

Review Biochemistry & Molecular Biology

The PCSK9 decade

Gilles Lambert et al.

JOURNAL OF LIPID RESEARCH (2012)

Review Biochemistry & Molecular Biology

The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy

S. Arnould et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2011)

Article Biotechnology & Applied Microbiology

Rapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at Scale

Martin Lock et al.

HUMAN GENE THERAPY (2010)

Article Immunology

Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses

Roberto Calcedo et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

Article Cardiac & Cardiovascular Systems

The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population

Amanda J. Hooper et al.

ATHEROSCLEROSIS (2007)

Article Genetics & Heredity

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote

Zhenze Zhao et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2006)

Article Multidisciplinary Sciences

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

S Rashid et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)